Alluma Inc is a licensed substance use treatment provider in Crookston, MN, listed in the SAMHSA treatment directory. An intensive outpatient program lets clients attend structured treatment several days a week while living at home. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adultsTreatment for co-occurring disorders plus serious emotional disturbance (SED) in children
Medications
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
IHS/Tribal/Urban (ITU) fundsMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than Medicaid
Ages served
Children/AdolescentsYoung AdultsSeniors
Accreditation
State substance use treatment agencySAMHSA certification for opioid treatment program (OTP)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
Residential/24-hour residentialLong-term residentialShort-term residentialFederal, or any government funding for substance use treatment programsCash or self-payment
151 South 4th Street, Suite 401, Grand Forks, ND 58201
OutpatientResidential/24-hour residentialOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare
2424 32nd Avenue South, Suite 103, Grand Forks, ND 58201
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare